latest news releases from the newsroom
Crucell Secures Exclusive Patent License from NIH to Commercialize Ebola Vaccines
LEIDEN, Netherlands, March 18, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that it has obtained an exclusive license to certain patents of the National Institutes of Health (NIH), an agency of the U.S. Department of Health and Human Services, to develop and commercialize recombinant vaccines against Ebola.
Boehringer Ingelheim and MorphoSys Enlarge Collaboration
MARTINSRIED, Germany, March 18, 2005 (PRIMEZONE) -- Boehringer Ingelheim and MorphoSys AG (Frankfurt: MOR; Prime Standard Segment, TecDAX) announced today an expansion of their existing cooperation involving both research and therapeutic applications. Under the new contract, Boehringer Ingelheim has acquired an option to receive several exclusive licenses on new therapeutic antibody programs. The two companies presently have two therapeutic antibody programs in joint collaboration. Additionally, Boehringer Ingelheim will obtain access to MorphoSys' HuCAL GOLD(r) library for research purposes at a number of the firm's research facilities. The first installation site is intended to be Boehringer Ingelheim's site in Vienna, Austria. MorphoSys will receive a technology access fee, annual license fees and optional R&D funding over the five-year collaboration term. For therapeutic antibodies emerging from the collaboration, Boehringer Ingelheim will pay milestone fees and royalties to MorphoSys. Financial details of the agreement were not disclosed.
Taitron Components Inc
Taitron Reports Fourth Quarter and Year-End 2004 Results
LOS ANGELES, March 17, 2005 (PRIMEZONE) -- Taitron Components Incorporated (Nasdaq:TAIT) today announced financial results for the fourth quarter and year-ended December 31, 2004. Net sales for 2004 were $9.4 million, compared with $9.5 million for 2003. Net loss was $248,000 for 2004, or $0.05 loss per basic and diluted share, compared with a net loss of $387,000 for 2003, or $0.07 loss per basic and diluted share. The Company also reported net sales of $1.8 million for the fourth quarter in 2004, compared with $1.9 million for the same period of 2003. Net loss was $311,000 for the fourth quarter of 2004, or $0.06 loss per basic and diluted share, compared with net loss of $523,000 for the same period of 2003, or $0.09 loss per basic and diluted share.
Transmeridian Exploration, Inc.
Transmeridian Reports Year End 2004 Results and Proved Reserves
HOUSTON, March 17, 2005 (PRIMEZONE) -- Transmeridian Exploration, Inc. (OTCBB:TMXN) reported a net loss of $4.0 million, or $0.05 per share, on revenues of $3.9 million for the year ended December 31, 2004, as compared to a net loss of $5.7 million, or $0.09 per share, on $0.8 million revenues for the year ended December 31, 2003.
ER Urgent Care Holdings Inc
ER Urgent Care to Participate In Pilot Program
MIAMI, March 17, 2005 (PRIMEZONE) -- ER Urgent Care Centers (Pink Sheets:ERUG) is pleased to announce that it is in discussions with DSS, Inc. to participate in a pilot program to bring DSS systems, software and infrastructural capabilities and technologies to the commercial marketplace. DSS, Inc. uses advanced technologies to provide software integration for the Veterans Administration's VISTA (Veterans Information Systems and Technologies Architecture) CPRs. ER Urgent Care Centers' executive director Jerry Miller comments, "We believe DSS, Inc. may have the most efficient and effective Medical Record Systems and Administrative Programs, and may prove to be an asset in our future plans of national expansion." Mr. Miller goes on to say that, "As a result of our meeting last December, we believe the practice side of DSS systems capabilities will keep ER Urgent Care Centers on the cutting edge of the delivery of health care."
EMS Technologies, Inc.
EMS Technologies Announces Fourth Quarter 2004 Results
ATLANTA, March 17, 2005 (PRIMEZONE) -- EMS Technologies, Inc. (Nasdaq:ELMG) today reported earnings from continuing operations of $917,000, or $.08 per share, on revenues of $69 million for the fourth quarter of 2004, and earnings of $4.4 million, or $.39 per share, on revenues of $260 million for the fiscal year 2004.
Blyth, Inc. Increases Semi-Annual Cash Dividend by 11 Percent
GREENWICH, Conn., March 17, 2005 (PRIMEZONE) -- Blyth, Inc. (NYSE:BTH), a leading designer and marketer of home decor and home fragrance products, today announced that it has declared a semi-annual cash dividend of $0.21 per share on the Company's common stock for the six months ended January 31, 2005. This represents an increase of $0.02 per share, or approximately 11%, above the most recent semi-annual dividend. The semi-annual dividend, authorized at the March 17, 2005 Board of Directors meeting, will be payable to shareholders of record as of April 29, 2005, and will be paid on May 13, 2005.
Betting Favorite Yellow Jackets Ready to Sting G. Washington Colonials
MONTREAL, March 17, 2005 (PRIMEZONE) -- The NCAA Tournament brackets have been released, and March Madness has hit college basketball courts around the country. Water cooler bookies log bets from office workers, Las Vegas sportsbooks race to create betting propositions, and online gamblers browse their favorite Internet site eager to place their bets. From college dorm rooms to busy call centers located in Canada, Costa Rica and Antigua, sports bettors and the gaming industry alike are ready for action.